When facing a disease that kills up to 70% of those who are infected, and no accepted treatment yet exists, should patients be subjected to clinical trials in which they might receive a placebo? Carefully monitoring the outcomes of different experimental treatments might be a more ethical approach. PRINCETON – It may, in the end, turn out to be fortunate that a handful of people in developed count